The Spanish Competition Authority initiates proceedings against two pharmaceutical companies for abuse of dominant position (Leadiant Biosciences Spa / Leadiant Biosciences)

The CNMC initiates disciplinary proceedings against Leadiant Biosciences Spa and Leadiant Biosciences LTD for alleged practices prohibited by the Antitrust Law* It is investigating a potential abuse of their dominant market position in Spain involving the manufacture and supply of the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Spanish Competition Authority, The Spanish Competition Authority initiates proceedings against two pharmaceutical companies for abuse of dominant position (Leadiant Biosciences Spa / Leadiant Biosciences), 22 December 2020, e-Competitions December 2020, Art. N° 98542

Visites 91

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues